Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
45,101,565
-
Total 13F shares
-
7,733,371
-
Share change
-
+7,733,371
-
Total reported value
-
$205,387,000
-
Price per share
-
$26.56
-
Number of holders
-
38
-
Value change
-
+$205,387,000
-
Number of buys
-
38
Institutional Holders of Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) as of Q3 2018
As of 30 Sep 2018,
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) was held by
38 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,733,371 shares.
The largest 10 holders included
Sofinnova Ventures Inc, SCOPIA CAPITAL MANAGEMENT LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, ALLIANCEBERNSTEIN L.P., MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, venBio Select Advisor LLC, Cormorant Asset Management, LP, and Artal Group S.A..
This page lists
38
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.